VACCINEX, INC. (VCNX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$16.19M | +24.3% |
| 2023 | -$21.38M | -12.1% |
| 2022 | -$19.07M | +24.6% |
| 2021 | -$25.30M | +11.7% |
| 2020 | -$28.65M | +6.7% |
| 2019 | -$30.71M | -21.5% |
| 2018 | -$25.28M | -18.2% |
| 2017 | -$21.39M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$16.19M | +24.3% |
| 2023 | -$21.38M | -12.1% |
| 2022 | -$19.07M | +24.6% |
| 2021 | -$25.30M | +11.7% |
| 2020 | -$28.65M | +6.7% |
| 2019 | -$30.71M | -21.5% |
| 2018 | -$25.28M | -18.2% |
| 2017 | -$21.39M | — |